MANUELA DELLA-TORRE: Open Payments
NPI 1417384868 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 23 payments from 17 companies in 2025. Trend: 2023 $1,904 · 2024 $2,057 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $258 |
| Medtronic, Inc. | 2 | $244 |
| ACADIA Pharmaceuticals Inc | 4 | $235 |
| Averitas Pharma Inc. | 1 | $145 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
Products named: NUPLAZID, QUTENZA, Auvelity, UZEDY, SYMPLICITY G3, AUSTEDO XR, PYRUKYND, Wegovy.
Industry payments across MI — which companies pay providers there.
